[Federal Register: March 11, 2003 (Volume 68, Number 47)]
[Notices]
[Page 11567]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11mr03-62]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 03F-0048]
BASF Corp.; Filing of Food Additive Petition (Animal Use)--
Conjugated Linoleic Acid
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that BASF
Corp. has filed a petition proposing that the food additive regulations
be amended to provide for the safe use of conjugated linoleic acid in
animal feed.
DATES: Submit written or electronic comments by May 26, 2003.
ADDRESSES: Submit written comments to the Dockets Management Branch
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. Submit electronic comments to http://www.fda.gov/
dockets/ecomments.
FOR FURTHER INFORMATION CONTACT: Sharon A. Benz, Center for Veterinary
Medicine (HFV-228), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-827-6656, e-mail: sbenz@cvm.fda.gov.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food
additive petition (FAP 2250) has been filed by BASF Corp., 3000
Continental Dr.-North, Mount Olive, NJ 07828-1234. The petition
proposes to amend the food additive regulations in part 573 Food
Additives Permitted in Feed and Drinking Water of Animals (21 CFR part
573) to provide for the safe use of conjugated linoleic acid (CLA) as a
source of fatty acids in swine diets at levels not to exceed 1 percent
in complete feed.
The potential environmental impact of this action is being
reviewed. To encourage public participation consistent with regulations
issued under the National Environmental Policy Act (40 CFR 1501.4(b)),
the agency is placing the environmental assessment submitted with the
petition that is the subject of this notice on public display at the
Dockets Management Branch (see ADDRESSES) for public review and
comment.
Interested persons may submit to the Dockets Management Branch (see
ADDRESSES) written or electronic comments regarding this document.
Submit a single copy of electronic comments to http://www.fda.gov/
dockets/ecomments
or two hard copies of any written comments, except
that individuals may submit one hard copy. Comments are to be
identified with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Dockets Management
Branch between 9 a.m. and 4 p.m., Monday through Friday. FDA will also
place on public display any amendments to, or comments on, the
petitioner's environmental information without further announcement in
the Federal Register. If, based on its review, FDA finds that an
environmental impact statement is not required and this petition
results in a regulation, the notice of availability of the agency's
finding and the evidence supporting that finding will be published with
the regulation in the Federal Register in accordance with 21 CFR
25.40(c).
Dated: February 27, 2003.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 03-5641 Filed 3-10-03; 8:45 am]
BILLING CODE 4160-01-S